Khsiba Amal, Bradai Samir, Mahmoudi Moufida, Mohamed Asma Ben, Medhioub Mouna, Hamzaoui Lamine, Azouz Mohamed Mousadek
Gastroenterology Department, Mohamed Tahar Maamouri Hospital, Nabeul, Tunisia.
Pan Afr Med J. 2022 Aug 31;42:323. doi: 10.11604/pamj.2022.42.323.30089. eCollection 2022.
severe acute liver injury (SALI) formerly known as severe acute hepatitis is an acute inflammation of the liver with markers of liver injury (elevated transaminases) and signs of hepatocellular failure (jaundice and INR greater than 1.5) according to the latest definition of the European Association for the Study of the Liver (EASL). An important prognostic factor in SALI is the development of hepatic encephalopathy (HE) and thus its progression to acute liver failure (ALF), formerly known as acute severe hepatitis. The purpose of this study is to investigate factors predicting the development of hepatic encephalopathy during SALI.
we conducted a retrospective study of patients treated for SALI between January 2000 and December 2019. We divided patients into two groups depending on whether hepatic encephalopathy occurred. We performed an analytical study comparing the two groups according to their epidemiological, biological and evolutionary data.
data from the medical records of fifty-nine patients were collected. A virus was the most frequent cause (63%). Hepatic encephalopathy occurred in 15 patients (25.4%). Factors predicting the development of HE in univariate analysis were a delay in consultation of more than 9 days, an INR level of more than 2.45, a bilirubin level of more than 230 μmol/l, creatinine greater than 60.5 μmol/l, urea greater than 5.5 mmol/l and MELD score greater than 26.5 (p=0.023, p=0.017, p=0.0001, p=0.049, p=0.0001, p=0.0001 respectively). Autoimmune hepatitis and an undetermined cause were associated with the development of HE (p=0,003 and p=0,044, respectively). In multivariate analysis, autoimmune aetiology and a urea level above 5.5 mmol/l were significantly associated with the occurrence of HE. No statistically significant differences were found between the two groups with regard to age, sex and diabetes.
SALI is a rare disease, mainly due to a virus in our country. Predictive factors of HE are important for early identification of patients at risk of adverse outcomes.
严重急性肝损伤(SALI)以前称为严重急性肝炎,根据欧洲肝脏研究协会(EASL)的最新定义,它是一种肝脏的急性炎症,伴有肝损伤标志物(转氨酶升高)和肝细胞功能衰竭的体征(黄疸和国际标准化比值(INR)大于1.5)。SALI的一个重要预后因素是肝性脑病(HE)的发生,进而发展为急性肝衰竭(ALF),以前称为急性重型肝炎。本研究的目的是调查预测SALI期间肝性脑病发生的因素。
我们对2000年1月至2019年12月期间接受SALI治疗的患者进行了一项回顾性研究。根据是否发生肝性脑病将患者分为两组。我们根据患者的流行病学、生物学和病情演变数据进行了一项分析性研究,比较两组情况。
收集了59例患者的病历数据。病毒是最常见的病因(63%)。15例患者发生了肝性脑病(25.4%)。单因素分析中预测HE发生的因素包括就诊延迟超过9天、INR水平大于2.45、胆红素水平大于230μmol/l、肌酐大于60.5μmol/l、尿素大于5.5mmol/l以及终末期肝病模型(MELD)评分大于26.5(p分别为0.023、0.017、0.0001、0.049、0.0001、0.0001)。自身免疫性肝炎和病因不明与HE的发生相关(p分别为0.003和0.044)。多因素分析中,自身免疫性病因和尿素水平高于5.5mmol/l与HE的发生显著相关。两组在年龄、性别和糖尿病方面未发现统计学上的显著差异。
SALI是一种罕见疾病,在我国主要由病毒引起。HE的预测因素对于早期识别有不良结局风险的患者很重要。